Ligand Pharmaceuticals, Inc. (NASDAQ:LGND)

CAPS Rating: 1 out of 5

Develops and markets new drugs that address critical unmet medical needs in the areas of cancer, mens and womens health, skin diseases, osteoporosis, and metabolic, cardiovascular and inflammatory diseases.

Recs

0
Player Avatar benyboy (< 20) Submitted: 7/11/2012 6:20:06 AM : Outperform Start Price: $19.37 LGND Score: +24.34

jimmy boy did make a recommendation, the stock has been running with the bulls

Featured Broker Partners


Advertisement